Victory Capital Management Inc Relay Therapeutics, Inc. Transaction History
Victory Capital Management Inc
- $95.8 Billion
- Q2 2024
A detailed history of Victory Capital Management Inc transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 76,539 shares of RLAY stock, worth $496,738. This represents 0.0% of its overall portfolio holdings.
Number of Shares
76,539
Previous 68,859
11.15%
Holding current value
$496,738
Previous $571,000
12.61%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding RLAY
# of Institutions
183Shares Held
127MCall Options Held
1.7KPut Options Held
18K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$181 Million1.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$76 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$68.4 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY8.45MShares$54.8 Million4.77% of portfolio
-
Bellevue Group Ag Kuesnacht, V86.38MShares$41.4 Million0.7% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $780M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...